General Biologicals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	208.32	243.34	251.65	217.12	262.18	308.77
Short-Term Investments	395.94	391.41	-	-	88.9	60
Cash & Short-Term Investments	604.26	634.75	251.65	217.12	351.08	368.77
Cash Growth	208.67%	152.24%	15.90%	-38.16%	-4.80%	-22.13%
Accounts Receivable	85.96	68.8	43.2	84.36	57.18	42.31
Other Receivables	5.93	2.78	28.18	0.72	4.32	5.17
Receivables	91.88	71.58	71.38	85.09	61.5	47.49
Inventory	54.02	58.95	57.08	85.56	116.79	81.32
Prepaid Expenses	29.89	22.15	82.87	-	18.33	11.56
Other Current Assets	6.36	5.19	3.72	14.09	3.28	1.18
Total Current Assets	786.41	792.62	466.69	401.85	550.97	510.32
Property, Plant & Equipment	837.19	829.1	2,819	2,002	864.46	607.87
Long-Term Investments	394.61	409.07	40.45	38.16	36.68	38.52
Goodwill	-	21.61	21.61	20.68	20.68	20.68
Other Intangible Assets	47.64	30.51	32.71	36.19	41.09	44.58
Long-Term Accounts Receivable	-	15.63	53.49	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	11.93	18.91
Other Long-Term Assets	2,770	2,771	45.16	37.96	24.77	23.58
Total Assets	4,836	4,870	3,479	2,537	1,551	1,264

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	66.98	61.21	43.02	24.26	25.3	38.74
Accrued Expenses	-	28.48	19.24	18.51	12.2	12.95
Short-Term Debt	60	60	60	50	5	-
Current Portion of Long-Term Debt	-	58.88	41.04	1.59	1.57	3.24
Current Portion of Leases	9.16	8.6	107.67	117.73	10.1	7.75
Current Income Taxes Payable	1	3.61	-	-	-	-
Current Unearned Revenue	16.71	85.79	25.69	6.48	5.82	3.83
Other Current Liabilities	346.84	90.43	108.94	810.73	38.05	10.56
Total Current Liabilities	500.68	397	405.6	1,029	98.04	77.07
Long-Term Debt	1,940	1,966	1,697	33.54	0.13	1.71
Long-Term Leases	407.22	402.43	404.2	345.6	452.02	436.74
Long-Term Unearned Revenue	6.72	1,141	635.32	620.7	-	-
Pension & Post-Retirement Benefits	-	-	-	-	0.02	0.95
Long-Term Deferred Tax Liabilities	45.13	45.28	4.6	4.9	6.19	5.48
Other Long-Term Liabilities	1,138	45.06	46.35	6.65	301.11	7.84
Total Liabilities	4,038	3,997	3,193	2,041	857.51	529.79

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	708.25	708.25	608.25	598.25	598.25	598.25
Additional Paid-In Capital	122.47	122.85	99.28	87.8	87.8	87.8
Retained Earnings	-39.05	36.95	-428.4	-207.03	-8.23	44.05
Comprehensive Income & Other	4.79	2.65	5.46	16.12	12.71	1.42
Total Common Equity	796.45	870.69	284.59	495.13	690.52	731.51
Minority Interest	1.81	1.78	1.9	1.51	2.55	3.14
Shareholders' Equity	798.26	872.47	286.48	496.65	693.07	734.66
Total Liabilities & Equity	4,836	4,870	3,479	2,537	1,551	1,264

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2,416	2,496	2,310	548.46	468.82	449.44
Net Cash (Debt)	-1,812	-1,862	-2,058	-331.34	-117.74	-80.66
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-26.78	-29.74	-34.40	-5.54	-1.97	-1.35
Filing Date Shares Outstanding	70.05	70.83	60.83	59.83	59.83	59.83
Total Common Shares Outstanding	70.05	70.83	60.83	59.83	59.83	59.83
Working Capital	285.73	395.62	61.09	-627.45	452.94	433.25
Book Value Per Share	11.37	12.29	4.68	8.28	11.54	12.23
Tangible Book Value	748.81	818.57	230.26	438.27	628.76	666.26
Tangible Book Value Per Share	10.69	11.56	3.79	7.33	10.51	11.14
Buildings	-	583.66	50.02	50.02	49.85	49.86
Machinery	-	197.77	194.1	189.38	174.16	171.07
Construction In Progress	-	81.01	2,210	1,415	263.91	1.77
Leasehold Improvements	-	11.31	20.13	20.13	20.13	20.13